The supply chain is perhaps one of the most important, yet least understood facets within an often-complex clinical trial compass. Even more shockingly, just 15% of clinical trials overcome the various supply chain hurdles they face. Such a low success rate illustrates the major challenges that pharmaceutical and biotech companies must overcome, particularly those in Boston where so many biotech and pharma consulting firms are found. In this article, we explore the key obstacles in clinical trial supply chain management and how to improve efficiency and success.
Clinical Trial Supply Chain Management Cloud is Not Free of Challenges
Difficult Regulatory Compliance Requirements
Poring over a thicket of rules in various geographies can be intimidating. Following standards of compliance for Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) are essential, but cumbersome.
Logistical Coordination
Managing multiple vendors, delivery of supplies and customs regulations can extend timelines and contribute to the costs associated with coordinating global logistics.
Temperature Control
It is one of the most challenging areas in relation to temperature-sensitive biological samples or investigational medicinal products (IMPs), which necessitate complex devices for monitoring and regulating temperatures.
Inventory Management
Trial materials must be carefully managed so that there is neither excess nor shortage available. Having too many of them will result in waste to dispose of, and there may be no procedures if they are understocked.
Integrity and Traceability of Data
The traceability of data in between the supply chain, and maintaining its integrity is crucial. Missing any of these checkpoints can jeopardize the integrity of a trial and fall short in compliance leading to penalties by regulators.
Potential Solutions
Hiring Expert Consulting Firms
Specialized biotech and pharma consulting firms in Boston with optimal blend of industry knowledge and location experience can guide you through this complexity. These firms provide deep expertise and experience, offering strategic guidance and operational assistance.
Advanced Technology Adoption
To alleviate supply chain risks, adoption of new tech like blockchain-in-traceability, IoT devices for live temperature readouts and artificial intelligence in forecasting inventory can prove to be extremely instrumental.
Collaborative Platforms
Leveraging collaborative platforms which tie all stakeholders (which in clinical parlance refers to everyone from decision makers at the sponsor level, CROs, suppliers and regulators) together allows for transparency, quicker adjustments of processes and parties working in tandem.
Training and Development
Regular training and capacity building of staff engaged in SCM can lead to better regulatory compliance and improved operational efficacy.
Risk Management Strategies
Establishing strong risk management strategies that encompass contingency plans, and regular audits can ready organizations to respond quickly and effectively to supply chain challenges.
Conclusion
Only 15% of clinical trials successfully navigate supply chain hurdles; hence the need for innovation and specialists in this area. The confluence of technology, specialized consulting firms and the investment being made by many enterprises in putting better risk management practices will help solve these complexity barriers and significantly enhance the efficiency of the clinical trial industry. BioBoston Consulting is at the leading edge of this change, with the skills and guidance to help us through the complicated world of clinical trial supply chains.
Addressing these problems directly allows the industry to bring more trials to a successful conclusion, helping speed up new and potentially life-saving medicines.
Get in touch with BioBoston Consulting today or visit our site to know how we can help you and your organization.
